To test the hypothesis that ARID1A regulates SCLC proliferation and genome stability through c-MYC and PARP1 modulation, we performed cell viability and clonogenic assays in ARID1A-overexpressing SCLC cells with ectopic c-MYC or PARP1 expression. The gene discussed is PARP1; the disease is small cell lung carcinoma.